Seventy five elderly depressed in-patients, ages ranging from 60 to 83 years, diagnosed as Major Depression according to DSM III were treated, under double-blind conditions, with 75 mg Amitriptyline (AMI) (26 patients), 60 mg Mianserin (MIA) (24 patients) or 150 mg Trazodone (TRZ) (25 patients) p.o.
Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients
β Scribed by C. Geretsegger; R. Fartacek; C. H. Stuppaeck; M. Mair; T. Platz; M. Heim
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 495 KB
- Volume
- 119
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a controlled double-blind study, sulpiride 10G200mg daily or placebo was administered over a five-month period to 22 and 24 depressive elderly outpatients. The majority of the patinets in both groups were diagnosed as suffering from relatively mild degrees of depression, i.e. from dysthymic disor
## Abstract ## Background The majority of the trials in the elderly are outpatient trials which excluded psychotic patients and patients with common comorbid physical disorders. Consequently information is lacking about the more complex cases of elderly depressed patients, as found in inpatient wa
Sixty-six elderly depressed patients received fluoxetine 20 mg (FLU) or amitriptyline 75 mg (AMI) for 42 days in a double blind parallel group study. Each week, subjects completed a test battery which is sensitive to the residual effects of psychoactive drugs. The results show that FLU and AM1 were
Moclobemide was compared with mianserin in a double-blind controlled study in elderly depressed patients. Sequential analysis of 1 1 pairs of patients found no significant difference between the drugs at the week 8 analysis. Unpaired comparison of the 26 patients completing four weeks' treatment als